Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease 论文

2020Nature Communications引用 561顶会
SARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery MethodsViral gastroenteritis research and epidemiology

Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease · 相关技术